NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA Approval NDA214313 (BAXTER HLTHCARE CORP)
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA Approval NDA214313 (BAXTER HLTHCARE CORP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE; Active ingredients: NOREPINEPHRINE BITARTRATE; Applicati
| Brand name | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE |
|---|---|
| Active ingredients | NOREPINEPHRINE BITARTRATE |
| Application number | NDA214313 |
| Sponsor | BAXTER HLTHCARE CORP |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 6 |
| First approval date | 20210115 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →